Artemis Investment Management LLP Gilead Sciences, Inc. Transaction History

Artemis Investment Management LLP

$6.17 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	SELL	$73.27 - $83.09 $22.6 Million - $25.6 Million	-308,269 Reduced 40.25%	457,565 $37.1 Million
Q3 2023 Oct 16, 2023	SELL	$73.94 - $80.67 $17.6 Million - $19.2 Million	-238,381 Reduced 23.74%	765,834 $57.4 Million
Q2 2023 Jul 19, 2023	BUY	$76.01 - $86.7 $21.9 Million - $25 Million	288,687 Added 40.35%	1,004,215 $77.4 Million
Q1 2023 May 05, 2023	BUY	$77.31 - $88.08 $46.8 Million - $53.3 Million	605,567 Added 550.71%	715,528 $59.4 Million
Q4 2022 Jan 25, 2023	SELL	$62.32 - $89.47 $487,093 - $699,297	-7,816 Reduced 6.64%	109,961 $0
Q3 2022 Oct 25, 2022	BUY	$59.54 - $68.01 $7.01 Million - $8.01 Million	117,777 New	117,777 $7.27 Million
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $4.4 Million - $5 Million	-67,855 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$67.69 - $73.03 $14.2 Million - $15.3 Million	-209,630 Reduced 75.55%	67,855 $4.74 Million
Q2 2021 Aug 04, 2021	BUY	$63.47 - $69.35 $8.23 Million - $8.99 Million	129,639 Added 87.69%	277,485 $19.1 Million
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $2.23 Million - $2.54 Million	37,090 Added 33.49%	147,846 $9.55 Million
Q4 2020 Jan 26, 2021	BUY	$56.65 - $64.55 $1.78 Million - $2.03 Million	31,473 Added 39.7%	110,756 $6.46 Million
Q3 2020 Oct 29, 2020	SELL	$62.1 - $78.08 $60,174 - $75,659	-969 Reduced 1.21%	79,283 $5.01 Million
Q2 2020 Jul 27, 2020	SELL	$72.34 - $84.0 $62,140 - $72,156	-859 Reduced 1.06%	80,252 $6.18 Million
Q1 2020 Apr 14, 2020	BUY	$62.63 - $80.22 $1.87 Million - $2.39 Million	29,837 Added 58.19%	81,111 $6.06 Million
Q4 2019 Jan 14, 2020	SELL	$61.62 - $67.78 $273,592 - $300,943	-4,440 Reduced 7.97%	51,274 $3.33 Million
Q3 2019 Oct 10, 2019	SELL	$62.51 - $69.0 $13.5 Million - $14.9 Million	-215,372 Reduced 79.45%	55,714 $3.53 Million
Q2 2019 Jul 24, 2019	BUY	$61.87 - $69.38 $132,092 - $148,126	2,135 Added 0.79%	271,086 $18.3 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $8.44 Million - $9.46 Million	-135,003 Reduced 33.42%	268,951 $17.5 Million
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $19 Million - $24.8 Million	313,599 Added 347.07%	403,954 $25.3 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $1.01 Million - $1.12 Million	14,188 Added 18.63%	90,355 $6.98 Million
Q2 2018 Aug 08, 2018	SELL	$64.88 - $75.68 $3.22 Million - $3.75 Million	-49,598 Reduced 39.44%	76,167 $5.4 Million
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $1.74 Million - $2.12 Million	23,826 Added 23.37%	125,765 $9.48 Million
Q4 2017 Feb 08, 2018	BUY	$71.15 - $83.52 $2.63 Million - $3.09 Million	37,015 Added 57.01%	101,939 $7.3 Million
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $559,140 - $662,734	7,754 Added 13.56%	64,924 $5.26 Million
Q2 2017 Aug 09, 2017	BUY	N/A	57,170	57,170 $4.05 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.

Account